VALUE DRIVEN GENERICS Trademark

Trademark Overview

On Monday, May 17, 2010, a trademark application was filed for VALUE DRIVEN GENERICS with the United States Patent and Trademark Office. The USPTO has given the VALUE DRIVEN GENERICS trademark a serial number of 85040462. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 6, 2023. This trademark is owned by Heritage Pharmaceuticals Inc.. The VALUE DRIVEN GENERICS trademark is filed in the Pharmaceutical Products category with the following description:

Full line of neurological, central nervous system, anti-inflammatory, cardiovascular, renal, anti-microbial, anti-neoplastic, immunomodulatory, hematopoietic, anticoagulant, thrombolytic, antiplatelet, estrogenic, progestin, androgen, thyroid, anti-thyroid, ophthalmic, histamine H2 receptor antagonist, proton pump antagonist, anti-emetic, anti-convulsant, anti-asthmatic and anti-diabetic pharmaceutical preparations
value driven generics

General Information

Serial Number85040462
Word MarkVALUE DRIVEN GENERICS
Filing DateMonday, May 17, 2010
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 6, 2023
Registration Number4064178
Registration DateTuesday, November 29, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 5, 2010

Trademark Statements

Goods and ServicesFull line of neurological, central nervous system, anti-inflammatory, cardiovascular, renal, anti-microbial, anti-neoplastic, immunomodulatory, hematopoietic, anticoagulant, thrombolytic, antiplatelet, estrogenic, progestin, androgen, thyroid, anti-thyroid, ophthalmic, histamine H2 receptor antagonist, proton pump antagonist, anti-emetic, anti-convulsant, anti-asthmatic and anti-diabetic pharmaceutical preparations
Disclaimer with Predetermined Text"GENERICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 6, 2023
Primary Code005
First Use Anywhere DateFriday, August 20, 2010
First Use In Commerce DateFriday, August 20, 2010

Trademark Owner History

Party NameHeritage Pharmaceuticals Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressEast Brunswick, NJ 08816
Party NameHeritage Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressEdison, NJ 08837
Party NameHeritage Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEdison, NJ 08837

Trademark Events

Event DateEvent Description
Friday, January 6, 2023CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Sunday, November 29, 2020COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, July 23, 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, July 23, 2019REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, July 16, 2019PETITION TO DIRECTOR - GRANTED
Wednesday, June 26, 2019TEAS RESPONSE TO PETITION TO DIRECTOR INQUIRY
Wednesday, June 19, 2019PETITION INQUIRY LETTER ISSUED
Tuesday, June 18, 2019ASSIGNED TO PETITION STAFF
Tuesday, November 20, 2018TEAS PETITION TO DIRECTOR RECEIVED
Tuesday, May 22, 2018POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Sunday, May 13, 2018TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Friday, May 11, 2018POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Thursday, May 10, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, April 30, 2018TEAS SECTION 8 & 15 RECEIVED
Tuesday, November 29, 2016COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, September 28, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 28, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 29, 2011REGISTERED-PRINCIPAL REGISTER
Friday, October 28, 2011NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, October 27, 2011LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, October 18, 2011ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, October 17, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 17, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 14, 2011ASSIGNED TO LIE
Tuesday, October 11, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 6, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 6, 2011NON-FINAL ACTION E-MAILED
Monday, June 6, 2011SU - NON-FINAL ACTION - WRITTEN
Tuesday, May 17, 2011STATEMENT OF USE PROCESSING COMPLETE
Thursday, May 12, 2011USE AMENDMENT FILED
Tuesday, May 17, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, May 12, 2011TEAS STATEMENT OF USE RECEIVED
Tuesday, November 30, 2010NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 5, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 5, 2010PUBLISHED FOR OPPOSITION
Tuesday, August 31, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, August 31, 2010ASSIGNED TO LIE
Tuesday, August 17, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 17, 2010EXAMINER'S AMENDMENT ENTERED
Tuesday, August 17, 2010NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, August 17, 2010EXAMINERS AMENDMENT E-MAILED
Tuesday, August 17, 2010EXAMINERS AMENDMENT -WRITTEN
Saturday, August 14, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, August 14, 2010NON-FINAL ACTION E-MAILED
Saturday, August 14, 2010NON-FINAL ACTION WRITTEN
Saturday, August 14, 2010ASSIGNED TO EXAMINER
Thursday, May 20, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 20, 2010NEW APPLICATION ENTERED

Related Keywords

generics driven value anti antagonist thyroid receptor histamine ophthalmic progestin androgen proton pump